Abstract
Invasive aspergillosis is one of the most important and fatal complications after liver transplant, especially in patients with involvement of the central nervous system. We present a case of a patient who developed cerebral and pulmonary aspergillosis, coinfected with cytomegalovirus, after liver transplant for toxic fulminant hepatitis. The patient was treated successfully with neurosurgical intervention and voriconazole. Voriconazole is considered more effective in cerebral aspergillosis than other anti-fungal agents due to the greater penetration into central nervous system and higher cerebrospinal fluid and brain tissue levels.
MeSH terms
-
Antifungal Agents / therapeutic use*
-
Biopsy
-
Brain Abscess / immunology
-
Brain Abscess / microbiology
-
Brain Abscess / therapy*
-
Brain Abscess / virology
-
Chemical and Drug Induced Liver Injury / diagnosis
-
Chemical and Drug Induced Liver Injury / etiology
-
Chemical and Drug Induced Liver Injury / surgery*
-
Cytomegalovirus Infections / immunology
-
Cytomegalovirus Infections / therapy*
-
Cytomegalovirus Infections / virology
-
Female
-
Humans
-
Immunocompromised Host
-
Immunosuppressive Agents / adverse effects
-
Invasive Pulmonary Aspergillosis / immunology
-
Invasive Pulmonary Aspergillosis / microbiology
-
Invasive Pulmonary Aspergillosis / therapy*
-
Liver Transplantation / adverse effects*
-
Lung Abscess / immunology
-
Lung Abscess / microbiology
-
Lung Abscess / therapy*
-
Magnetic Resonance Imaging
-
Middle Aged
-
Mushroom Poisoning / complications*
-
Mushroom Poisoning / diagnosis
-
Neuroaspergillosis / immunology
-
Neuroaspergillosis / microbiology
-
Neuroaspergillosis / therapy*
-
Neurosurgical Procedures*
-
Opportunistic Infections / immunology
-
Opportunistic Infections / microbiology
-
Opportunistic Infections / therapy*
-
Opportunistic Infections / virology
-
Tomography, X-Ray Computed
-
Treatment Outcome
-
Voriconazole / therapeutic use*
Substances
-
Antifungal Agents
-
Immunosuppressive Agents
-
Voriconazole